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Abstract We cloned a human PEX11 cDNA by expressed
sequence tag homology search using yeast Candida boidinii
PEX11, followed by screening of human liver cDNA library.
PEX11 encoded a peroxisomal protein Pex11p comprising 247
amino acids, with two transmembrane segments and a dilysine
motif at the C-terminus. Pex11p comigrated in SDS-PAGE with
a 28-kDa peroxisomal integral membrane protein (PMP28)
isolated from the liver of clofibrate-treated rats and was
crossreactive to anti-PMP28 antibody, thereby indicating
PEX11 to encode PMP28. Pex11p exposes both N- and C-
terminal parts to the cytosol. PEX11 was not responsible for ten
complementation groups of human peroxisome deficiency
disorders.
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1. Introduction
Peroxisomal proteins, including membrane proteins, are en-
coded by nuclear genes, translated on free polyribosomes in
the cytosol, mostly at their ¢nal sizes [1]. Peroxisomes are
formed by division of preexisting peroxisomes after posttrans-
lational import of newly synthesized proteins [1]. Genetic
analysis of peroxisome-de¢cient mutants of yeast and mam-
malian cells have led to identi¢cation of a number of protein
factors essential for peroxisome biogenesis [2,3]. Genetical
heterogeneities comprising 12 complementation groups
(CGs) have been identi¢ed in mammals, including humans
[4^12]. Thereby, more than 12 genes are likely to be involved
in mammalian peroxisome biogenesis. We have to date cloned
PEX2 [13], PEX6 encoding a member of the AAA ATPase
family [14], PEX12 [15,16], and PEX1 coding for another
AAA protein [17], by genetic phenotype complementation as-
say of CHO cell mutants. These PEX proteins, peroxins, were
required for peroxisome assembly in mammalian cells. Several
human orthologues of yeast peroxins have been isolated by
means of expressed sequence tag (EST) search on human da-
tabase using yeast PEX genes [18^21]. Six peroxin genes,
PEX2 [13,22], PEX5 for peroxisome targeting signal type 1
(PTS1) receptor [23,24], PEX6 [14,25,26], PEX12 [15,16,27],
PEX1 [17,19,20], and PEX10 [21] were shown to be respon-
sible for human peroxisome biogenesis disorders.
However, the process of membrane vesicle formation and
proliferation of peroxisomes is little understood, despite the
development of genetic approaches described above. Treat-
ment with peroxisome proliferators, including hypolipidemic
drugs such as clo¢brate, induces in rats a variety of peroxiso-
mal enzymes such as L-oxidation enzymes and proliferate per-
oxisomes [28,29]. Peroxisomal membrane biogenesis has been
investigated in mammals [1,30^34], including several reports
by making use of such inducible characteristics [30,31,35].
We herein isolated human PEX11 cDNA (HsPEX11) en-
coding a peroxin Pex11p, by EST homology search using
Candida boidinii (Cb) PEX11 [36]. Human Pex11p was recog-
nized by antibody raised against clo¢brate-inducible, 28-kDa
peroxisomal membrane protein (PMP28).
2. Materials and methods
2.1. Isolation of PMP28 and preparation of antisera
Peroxisomal membranes were prepared by sodium carbonate treat-
ment [37] of highly puri¢ed peroxisomes [38,39] from male Fisher F-
344 rats that had been treated for 7 days with clo¢brate [29]. PMP28
was isolated by preparative SDS-PAGE, as described [30]. Antisera to
PMP28 were raised in a rabbit as described [30].
2.2. Cell line
Wild-type CHO-K1 cells were cultured as described [8].
2.3. Cloning of human PEX11
Human EST AA476689 and R99800 showed high homology, 20%
identical at a deduced amino acid sequence level, in the region encod-
ing the N-terminal part comprising 100 amino acids of C. boidinii
PEX11 protein (formerly PMP30) [36]. Twenty subpools of human
liver cDNA library constructed in a vector pCMVSPORTI (Gibco
BRL) [17] were screened by PCR using nucleotide oligomers, sense
HsPEX11.F (5P-GGTTCAGACTAGGCAATGTGG-3P) and anti-
sense HsPEX11.R (5P-CTCGTTTCATCTGCAGGGAG-3P), corre-
sponding to nucleotide residues at positions 235^255 and 297^316,
of the EST AA476689 and R99800, respectively. One positive subpool
No. 19 was screened by colony hybridization using the resulting PCR
products as probe. Four positive colonies hybridized to the probe
were identi¢ed. A single clone, F6-19-7, was isolated.
2.4. Morphological analysis
Peroxisomes in CHO cells were visualized by indirect immuno£uo-
rescence light microscopy, as described [4]. We used rabbit antibodies
to PTS1 peptide [11]. Antigen-antibody complex was detected by
FITC-labelled sheep anti-rabbit immunoglobulin G antibody (Cap-
pel), under a Carl Zeiss Axioskop FL microscope.
2.5. Expression of epitope-tagged Pex11p
An epitope, £ag-tagging to the N-terminus of Pex11p was done by a
PCR-based technique. Flag-HsPEX11 was ampli¢ed using a forward
primer HsPEX11.FLAG.F (5P-GCGCGGATCCAGGACGCCTT-
CACCCGC-3P) and a reverse primer HsPEX11.FLAG.R (5P-
GCGCGTCGACACATACAACTCTTCATGCT-3P). The PCR prod-
ucts were blunt-ended, digested with BamHI, then ligated into a Bam-
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HI-ApaI (blunted) vector fragment containing £ag-tag sequence, or-
iginated from pUcD2HygW£ag-RnPEX12 [16]. C-terminal myc-tagging
to £ag-Pex11p was likewise done using a forward primer
HsPEX11.BglF (5P-GCGCAGATCTTGGACGCCTTCACCCGC-3P)
and a reverse primer HsPEX11.myc (5P-GCGCGGGCCCTCACAA-
GTCTTCTTCAGAAATAAGCTTTTGTTCGTCGACACGGGTC-
TTCAGCTTCATC-3P). A plasmid pUcD2HygW£ag-HsPEX11-myc
was constructed by inserting ApaI-BglII fragment of the PCR product
into a BamHI-ApaI vector fragment containing £ag-tag sequence de-
rived from pUcD2HygW£ag-HsPEX12. Flag-tagged Pex11p and £ag-
Pex11p-myc were detected using mouse monoclonal antibodies to £ag
(M2) (Scienti¢c Imazing Systems) and human c-myc (9E10) (Santa
Cruz Biotech), and Texas Red-labelled sheep anti-mouse IgG second
antibody (Amersham) in cells that had been permeabilized with 25 Wg/
ml of digitonin [15,40] or 0.1% Triton X-100.
2.6. In vitro transcription and translation of PEX11
SalI-XbaI fragment of pCMVSPORTWHsPEX11 and NotI
(blunted)-KpnI fragment of pUcD2HygW£ag-HsPEX11 were separately
inserted into XbaI-SalI site and HincII-KpnI site, respectively, of
pTZ19R vector (Amersham). In vitro translation of transcription
product of HsPEX11 or £ag-HsPEX11 in pTZ19R was done in a
rabbit reticulocyte lysate cell-free protein synthesizing system, using
[35S]methionine and [35S]cysteine as label, as described [41]. To reduce
nonspeci¢c binding, translation products were incubated, prior to
immunoprecipitation, with formaldehyde-¢xed and heat-inactivated
Staphylococcus aureus cells (Calbiochem), in 1% NP-40/10 mM Tris-
HCl, pH 7.4/150 mM NaCl/2 mM EDTA/1 mM phenylmethylsulfonyl
£uoride/50 U/ml of aprotinin/2 mg/ml of leupeptin/2 mg/ml of anti-
pain, and centrifuged. Supernatants were subjected to immunopreci-
pitation using antibodies to PMP28 and £ag, as described [8].
2.7. Other methods
Nucleotide sequence was determined by the dideoxy-chain termina-
tion method using a Dye-terminator DNA sequence kit (Applied Bio-
systems). Alignment was done using GENETYX-Mac program (SDC,
Tokyo). For Northern blotting, liver RNA was isolated from a rat
treated for 7 days with clo¢brate, and from an untreated rat. The blot
was hybridized with BamHI fragment (nucleotide residues at 115^598)
of HsPEX11 labelled with K-[32P]dCTP (Amersham). Western blot
analysis on polyvinylidene di£uoride membrane (Bio-Rad) was done
using a horseradish peroxidase-conjugated second antibody, donkey
anti-rabbit IgG antibody, and ECL Western blotting detection re-
agent (Amersham).
3. Results and discussion
3.1. Anti-PMP28 antibody
By treatment of rats with clo¢brate, PMP28 was highly
induced, while 22-kDa PMP [30] was at a normal level (Fig.
1, lanes 1 and 2). We raised antiserum against PMP28 by
immunizing rabbits with PMP28 isolated from liver peroxi-
somes of clo¢brate-treated rats. The antibody speci¢cally rec-
ognized PMP28 among numerous peroxisomal proteins in im-
munoblots of puri¢ed peroxisomes and homogenates from the
liver of clo¢brate-treated rats (Fig. 1, lanes 4 and 6). PMP28
was resistant to the sodium carbonate extraction [30,37],
thereby suggesting PMP28 to be an integral membrane pro-
tein (lane 5). PMP28 was evidently induced by clo¢brate,
barely detectable in peroxisomes as well as homogenates
from the liver of untreated rats (lanes 3 and 7).
3.2. Cloning of PMP28 cDNA
As a step to investigate biogenesis of PMP28, we attempted
to clone a cDNA for mammalian PMP28. We used the EST
homology search method as a cDNA cloning strategy. We
¢rst selected yeast PMP Pex11p as a potential candidate,
judged from its molecular mass and inducible property
[36,42]. BLAST search, using a TBLASTN program [43] for
mammalian orthologue of C. boidinii PEX11 (CbPEX11) [36],
identi¢ed a cDNA clone, human EST: AA476689. We did
further BLAST search using a human EST clone AA476689
and identi¢ed human EST: R99800. We isolated four positive
clones by screening a human liver cDNA library with
AA476689- and R99800-derived probes; one plasmid F6-19-
7 contained 1205-bp cDNA with an ORF encoding a 247-
amino acid protein of 28 353 Da (Fig. 2). Homology analysis
suggested that this ORF was most likely to encode human
orthologue of the CbPEX11 and PEX11 from Saccharomyces
cerevisiae (ScPEX11) [42,44]. Thereby, we termed this cDNA
HsPEX11. The HsPEX11 protein, HsPex11p, was shorter by
nine amino acids than CbPex11p in the primary sequence, but
longer by 11 amino acids than ScPex11p. The average amino
acid identity to CbPex11p and ScPex11p was 20% and 25%,
respectively. Two putative membrane-spanning, hydrophobic
segments were identi¢ed in human Pex11p (Fig. 2, overlines).
Human Pex11p also contained a dilysine motif, ER retention
motif [45], at the C-terminus and a potential N-glycosylation
site, Asn at residue 9, in the N-terminal part, both of which
were found neither in CbPex11p nor ScPex11p (Fig. 2).
The size of PMP28 was indistinguishable from that of
Pex11p synthesized in vitro by coupled transcription/transla-
tion which was speci¢cally immunoprecipitated by anti-
PMP28 antibody (Fig. 3A, lanes 1^4), thereby indicating
that a cloned PEX11 cDNA encodes bona ¢de PMP28. This
result implies the synthesis of PMP28, i.e. Pex11p, at its ¢nal
size, consistent with a general rule for peroxisomal proteins
[1]. Moreover, in vitro synthesized £ag-Pex11p (Fig. 3A, lanes
5^7) as well as £ag-Pex11p expressed in CHO-K1 cells (data
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Fig. 1. Western blot analysis with anti-PMP28 antibody. Lanes 1
and 2, Coomassie blue-stained SDS-PAGE gel; lanes 3^7, immuno-
blot with rabbit anti-PMP28 antibody. Lanes: 1, normal rat liver
peroxisomes (NP, 50 Wg); 2, liver peroxisomes (CP, 30 Wg) from clo-
¢brate-treated rats; 3, normal peroxisomes (15 Wg); 4^6, peroxi-
somes (15 Wg), membranes from peroxisomes (15 Wg), and liver ho-
mogenates (100 Wg), respectively, from clo¢brate-treated rats; 7,
normal rat liver homogenates (100 Wg). Molecular mass markers are
on the left. The solid and open arrowheads indicate PMP28 and 22-
kDa PMP [30], respectively.
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not shown) were recognized by both antibodies to £ag and
PMP28, con¢rming the PEX11 to encode PMP28.
Peroxisomes and peroxisomal proteins are induced in rat
liver by administration of hypolipidemic compounds, such
as clo¢brate [28,29]. On Northern blotting, PEX11 mRNA
was detected as a single band of about 1.5 kb in liver RNA
from clo¢brate-treated rat (Fig. 3B, upper panel). PEX11
mRNA was highly induced in rats by clo¢brate, consistent
with the result in immunoblot (see Fig. 1), under which
acyl-CoA oxidase mRNA was elevated (middle panel), by
about 50-fold [16,29]. It is interesting to note that PMP
with an estimated mass of 26 kDa was inducible in rats by
treatment with di(2-ethylhexyl)phthalate, a plasticizer, or thy-
roid hormones [31,35]. Accordingly, 26-kDa PMP is likely to
be the same protein as PMP28 cloned in the present work.
3.3. Intracellular localization and topology of Pex11p
Subcellular localization of Pex11p was determined by im-
muno£uorescent microscopy of ectopically expressed Pex11p
that had been tagged with an epitope at its N- or C-terminus.
When N-terminally £ag-tagged HsPEX11 was expressed in
CHO-K1 cells, Pex11p was detected in a punctate staining
pattern (Fig. 4A, a). The pattern was superimposable on
that obtained using anti-PTS1 antibody (Fig. 4A, b), thereby
suggesting that £ag-Pex11p was localized to peroxisomes.
Similar results were obtained when C-terminally epitope-
tagged Pex11p-myc was expressed in CHO-K1 (Fig. 4B, a
and b).
Membrane topology of Pex11p was determined by a di¡er-
ential permeabilization procedure. CHO-K1 cells expressing
£ag-Pex11p were permeabilized with 25 Wg/ml of digitonin,
under which plasma membranes are selectively permeabilized
and intraperoxisomal proteins are inaccessible to exogenous
antibodies [15,16,40]. Flag-Pex11p was observed in a punctate
staining pattern, whereas there was nearly no staining of cells
with anti-PTS1 antibody (Fig. 4A, c and d). Similar results,
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Fig. 3. Identi¢cation of Pex11p. A: Size comparison of in vitro
transcription/translation product of human PEX11 cDNA and rat
liver PMP28. 35S-labelled, in vitro transcription/translation product
of HsPEX11 and rat liver peroxisomes was subjected to SDS-PAGE
and transferred to polyvinylidene di£uoride membrane. 35S protein
bands in lanes 1^3 and 5^7 were detected by a FujiX BAS1000 Bio-
Imaging Analyzer at an exposure for 16 h; immunodetection was
done for lane 4 with anti-PMP28 antibody. Lanes: 1, in vitro tran-
scription/translation product (1 Wl) of HsPEX11 ; 2 and 3, immuno-
precipitation of 35S-Pex11p (1 Wl) was done with preimmune and
anti-PMP28 immune sera, respectively; 4, liver peroxisomes (CP, 20
Wg) from clo¢brate-treated rats; 5, in vitro transcription/translation
product (1 Wl) of £ag-HsPEX11 ; 6 and 7, immunoprecipitation of
35S-£ag-Pex11p (1 Wl) was done with antibodies to £ag and PMP28,
respectively. Solid and open arrowheads indicate 35S-Pex11p and
35S-£ag-Pex11p, respectively. B: Northern blot analysis of PEX11
mRNA. Total RNA (20 Wg) from the livers of a normal (NL) and
a clo¢brate-treated (CL) rat was separated, transferred to Zeta-
Probe GT membrane (Bio-Rad), and hybridized with 32P-labelled
cDNA probes for human PEX11 (upper panel) and rat acyl-CoA
oxidase (AOx, middle panel), respectively. Human L-actin (lower
panel) cDNA was used as a control probe to check the amount of
RNA loaded. Washing was done twice with 0.15 M NaCl/10 mM
sodium phosphate, pH 7.4/1 mM EDTA/0.5% SDS at 60‡C. PEX11
mRNA band was detected using a FujiX BAS1000 Bio-Imaging An-
alyzer (Fuji Photo Film) at an exposure for 16 h; AOx and L-actin
bands, by autoradiography at exposures for 28 and 24 h, respec-
tively.
Fig. 2. Amino acid sequence alignment of human PEX11 protein
and Pex11p from C. boidinii and S. cerevisiae. Deduced amino acid
sequence of human (Hs) PEX11 was compared with those of
Pex11p from yeast C. boidinii (Cb) and S. cerevisiae (Sc). (-) is a
space. Identical amino acids between human and other species are
shaded. Putative membrane-spanning segments are overlined. Con-
served lysine residues in the dilysine motif are designated by dots;
open arrowhead indicates the position of a potential N-glycosylation
site. The DDBJ/EMBL/GenBank database accession number for the
human PEX11 cDNA is AB015594.
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including detection of C-terminally tagged myc on post-per-
meabilization with 25 Wg/ml of digitonin, were obtained when
HsPEX11-myc was expressed in CHO-K1 cells (Fig. 4B, c and
d). Taken together, these results strongly suggest that both N-
and C-terminal parts of Pex11p are exposed to the cytosol,
presumably anchored by two membrane-spanning segments
(see Fig. 2). It is noteworthy that ScPex11p was shown to
be a peroxisomal integral membrane protein [42].
Furthermore, to investigate whether two conserved lysine
residues in the dilysine motif are essential for peroxisomal
targeting of Pex11p, we mutated and expressed £ag-HsPEX11
in CHO-K1 cells. Pex11p with mutation of residues 243K245K
to 243S245S in the motif was detected in a punctate staining
pattern, colocalized with PTS1-positive vesicles, peroxisomes,
thereby indicating the mutation of the dilysine motif to show
no apparent e¡ect on localization of Pex11p (data not shown).
It is presently unknown if ER plays a role in peroxisome
biogenesis in mammals. Flag-Pex11p mutated at the potential
N-glycosylation site, 9N to 9D, was likewise detected in punc-
tate structures colocalized with PTS1 proteins, implying no
discernible change in Pex11p localization (data not shown).
Moreover, this N9D mutation did not change the mobility of
Pex11p in SDS-PAGE, suggesting no glycosylation of human
Pex11p expressed in CHO cells (data not shown). We should
await further study to delineate the potential role of ER in
biogenesis of Pex11p.
Collectively, the data in the present work demonstrate that
PEX11 encodes peroxisome proliferator-inducible PMP28.
PEX11 was not responsible for peroxisome de¢ciency of 12
di¡erent CGs so far identi¢ed [3], including ten human CGs
and two CHO CGs distinct from human CGs, as assessed by
transfection of HsPEX11 (data not shown). Pex11p was sug-
gested to be involved in proliferation of peroxisomes in the
yeast S. cerevisiae [42,44] and C. boidinii [36]. No apparent
proliferation of peroxisomes was noted, however, when
HsPEX11 was expressed in CHO-K1 cells (see Fig. 4).
Pex11p may function as a peroxisome biogenesis regulator,
possibly by interacting with other PEX proteins [2,3,18], in-
cluding RING peroxins, Pex2p [13,22,46] and Pex12p
[15,16,27], AAA family peroxins Pex1p [17,19,20] and Pex6p
[14,25,26], a tetratricopeptide repeat (TPR) protein Pex5p
(PTS1 receptor) [23,24,47], a WD motif protein Pex7p
(PTS2 receptor) [48^50], and Pex13p (PTS1 receptor docking
protein) presumed in mammals [51]. Functional role of
Pex11p in peroxisome biogenesis in mammals remains to be
investigated.
Note: Passreiter et al. [52] very recently cloned rat PEX11,
showing interaction of Pex11p with ADP-ribosylation factor
and coatomer.
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